Covidien PLC, the medical supplies giant that is incorporated in Ireland but has its corporate headquarters in Mansfield, said that its SpiderFX device has received clearance from the Food and Drug Administration. The SpiderFX is an embolic protection device that is used to treat severely calcified lesions in conjunction with plaque excision in arteries, the company said in a press release. Embolic protection devices are used to capture and remove debris that becomes dislodged during an interventional procedure.
For more from BostonGlobe.com, sign up or log in below
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Get FREE access as part of your print subscription.
Click to continue reading this article or to log in to BostonGlobe.com.